Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades

BACKGROUND: The timing of the launch of a new drug is an important factor that determines access for patients. We evaluated patient access to pharmaceuticals in 30 European markets over the past two decades. METHODS: Launch dates were extracted from the IQVIA (formerly IMS) database for 30 European...

Descripción completa

Detalles Bibliográficos
Autores principales: Büssgen, Melanie, Stargardt, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714155/
https://www.ncbi.nlm.nih.gov/pubmed/36451186
http://dx.doi.org/10.1186/s12913-022-08866-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714155/
https://www.ncbi.nlm.nih.gov/pubmed/36451186
http://dx.doi.org/10.1186/s12913-022-08866-7

Ejemplares similares